SIRT4 and Hepatic fibrosis: In conclusion, in the current work we demonstrated that modest overexpression of SIRT4 in the liver protected against fibrosis by inhibiting the transformation of glutamate into α-KG in the TCA cycle, thereby reducing the proliferative activity of HSCs and alleviating the development of liver fibrosis (Fig. 7).